Tatva Chintan Pharma Chem (NSE:TATVA) Net Income From Continuing Operations : ₹176 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Tatva Chintan Pharma Chem's net income from continuing operations for the three months ended in Sep. 2024 was ₹-7 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was ₹176 Mil.

Tatva Chintan Pharma Chem Net Income From Continuing Operations Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Net Income From Continuing Operations Chart

Tatva Chintan Pharma Chem Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

475.97

606.96

1,041.21

447.79

435.68

Tatva Chintan Pharma Chem Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income From Continuing Operations	Get a 7-Day Free Trial														77.81	34.55	96.14	52.09	-6.64

Tatva Chintan Pharma Chem Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹176 Mil.

Tatva Chintan Pharma Chem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (NSE:TATVA) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

543321:India

Address

Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010

Website

https://www.tatvachintan.com

Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines